Market Cap 367.59M
Revenue (ttm) 139.93M
Net Income (ttm) -27.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -19.62%
Debt to Equity Ratio 0.00
Volume 906,200
Avg Vol 965,402
Day's Range N/A - N/A
Shares Out 41.12M
Stochastic %K 82%
Beta 1.14
Analysts Hold
Price Target $10.39

Company Profile

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 521 7830
Address:
100 Columbia, Aliso Viejo, United States
StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 9:13 PM
$RXST Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.22 down -46.67% YoY • Reported revenue of $32.61M down -18.92% YoY • RxSight provided full year 2026 revenue guidance of $120M, reflecting lower year-over-year LDD placements, and gross margin of 70% to 72% driven by higher per-unit manufacturing costs.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 9:13 PM
$RXST Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.22 down -46.67% YoY • Reported revenue of $32.61M down -18.92% YoY • RxSight provided full year 2026 guidance, projecting revenue of $120.0 to $135M, gross margin of 70% to 72%, and operating expenses between $150M and $160M, reflecting lower LDD placements.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 21 at 10:48 PM
$RXST Current Stock Price: $8.63 Contracts to trade: $7.5 RXST Mar 20 2026 Call Entry: $2.40 Exit: $3.07 ROI: 28% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
FoxySprout
FoxySprout Feb. 20 at 12:01 PM
$RXST Leadership & Organizational Developments!!
0 · Reply
topstockalerts
topstockalerts Feb. 17 at 1:08 PM
$RXST there it goes!! 🚨
0 · Reply
char13
char13 Feb. 17 at 12:27 PM
$PLYX 100% $BODI 12% $CMPS 16% $RXST 25% $OBAI 92%
0 · Reply
char13
char13 Feb. 17 at 10:50 AM
$RXST value play
0 · Reply
char13
char13 Feb. 17 at 10:48 AM
$RXST cataract surgery tool with a bunch of revenue. Looks like a winner here
0 · Reply
Ericvule
Ericvule Feb. 13 at 4:24 PM
$RXST still here…let’s get it
0 · Reply
Horseheels
Horseheels Feb. 11 at 2:59 PM
0 · Reply
Latest News on RXST
RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript

Feb 25, 2026, 11:17 PM EST - 7 hours ago

RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript


RxSight, Inc. Announces Chief Financial Officer Transition

Dec 22, 2025, 5:15 PM EST - 2 months ago

RxSight, Inc. Announces Chief Financial Officer Transition


RxSight, Inc. (RXST) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 8:51 PM EST - 4 months ago

RxSight, Inc. (RXST) Q3 2025 Earnings Call Transcript


RxSight, Inc. Reports Third Quarter 2025 Financial Results

Nov 5, 2025, 4:05 PM EST - 4 months ago

RxSight, Inc. Reports Third Quarter 2025 Financial Results


The Bottom Fishing Club - RxSight: A Ski-Jump Reversal Pattern?

Sep 22, 2025, 8:49 AM EDT - 5 months ago

The Bottom Fishing Club - RxSight: A Ski-Jump Reversal Pattern?


RxSight, Inc. (RXST) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 2:29 PM EDT - 7 months ago

RxSight, Inc. (RXST) Q2 2025 Earnings Call Transcript


RxSight, Inc. Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:05 PM EDT - 7 months ago

RxSight, Inc. Reports Second Quarter 2025 Financial Results


StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 9:13 PM
$RXST Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.22 down -46.67% YoY • Reported revenue of $32.61M down -18.92% YoY • RxSight provided full year 2026 revenue guidance of $120M, reflecting lower year-over-year LDD placements, and gross margin of 70% to 72% driven by higher per-unit manufacturing costs.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 9:13 PM
$RXST Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.22 down -46.67% YoY • Reported revenue of $32.61M down -18.92% YoY • RxSight provided full year 2026 guidance, projecting revenue of $120.0 to $135M, gross margin of 70% to 72%, and operating expenses between $150M and $160M, reflecting lower LDD placements.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 21 at 10:48 PM
$RXST Current Stock Price: $8.63 Contracts to trade: $7.5 RXST Mar 20 2026 Call Entry: $2.40 Exit: $3.07 ROI: 28% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
FoxySprout
FoxySprout Feb. 20 at 12:01 PM
$RXST Leadership & Organizational Developments!!
0 · Reply
topstockalerts
topstockalerts Feb. 17 at 1:08 PM
$RXST there it goes!! 🚨
0 · Reply
char13
char13 Feb. 17 at 12:27 PM
$PLYX 100% $BODI 12% $CMPS 16% $RXST 25% $OBAI 92%
0 · Reply
char13
char13 Feb. 17 at 10:50 AM
$RXST value play
0 · Reply
char13
char13 Feb. 17 at 10:48 AM
$RXST cataract surgery tool with a bunch of revenue. Looks like a winner here
0 · Reply
Ericvule
Ericvule Feb. 13 at 4:24 PM
$RXST still here…let’s get it
0 · Reply
Horseheels
Horseheels Feb. 11 at 2:59 PM
0 · Reply
erevnon
erevnon Jan. 20 at 2:50 PM
Piper Sandler maintains RxSight $RXST at Neutral and raises the price target from $10 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 20 at 1:45 PM
$RXST Share Price: $9.82 Contract Selected: Jun 18, 2026 $10 Calls Buy Zone: $1.34 – $1.65 Target Zone: $2.37 – $2.90 Potential Upside: 67% ROI Time to Expiration: 148 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 16 at 4:23 PM
$RXST RSI: 40.72, MACD: -0.4033 Vol: 0.93, MA20: 10.53, MA50: 10.80 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
RunnerSignals
RunnerSignals Jan. 12 at 9:36 PM
Oversold Bounce Watch $RXST $DDOG $ZBIO $LOGI $CSGP RSI washed out then buyers showed up Is this the start of real rebounds or just a pause before the next move Dive into the full analysis https://stocksrunner.com/news/2026-01-12-oversold-stocks-to-buy-as-rsi-rebounds-signal-entries
0 · Reply
drockafeller
drockafeller Jan. 12 at 8:59 PM
$RXST Movement in the right direction!
0 · Reply
Stock_Catcher
Stock_Catcher Jan. 12 at 3:00 PM
$RXST trending
0 · Reply
Siesta94
Siesta94 Jan. 9 at 3:13 PM
$RXST Alcon could buyout RxSight now that they no longer can take over Staar Surgical !!
2 · Reply
nineballer
nineballer Jan. 9 at 3:13 PM
$RXST What happened today?
0 · Reply
sstephen
sstephen Jan. 9 at 3:08 PM
$RXST please short this back to the 6’s for me. Getting cash ready to buy.
1 · Reply
BillionerOfKing
BillionerOfKing Dec. 30 at 12:21 AM
$RXST Current Stock Price: $10.74 Contracts to trade: $10 RXST Jan 16 2026 Call Entry: $2.13 Exit: $2.77 ROI: 30% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
FrequentistFathom
FrequentistFathom Dec. 26 at 7:07 AM
$RXST Volatility reflects unresolved questions around how strategy converts into durable results. Strategic direction should avoid unnecessary detours. Visible traction across indicators would support the story. Proof, rather than potential, becomes the key differentiator.
0 · Reply
sstephen
sstephen Dec. 23 at 7:44 PM
$RXST what changes made a drastic decrease happen.
1 · Reply